Accumetrics secures $7M in first round financing
Accumetrics has raised an additional $7 million in the first round of capital financing and has secured $24 million total in new capital.

The San Diego-based Accumetrics, a developer of the VerifyNow platelet testing system, said that this round of financing results are from its existing investors: Arnerich Massena, BBT Fund/Apothecary Capital, Essex Woodlands Health Ventures, Rivervest and Kaiser Permanente.

Accumetrics said that the financing will be used to complete the GRAVITAS trial and the CLIA waiver application for the VerifyNow P2Y12 test, which is under review by FDA, and is used to assess patient’s responses to antiplatelet therapy.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup